On Invalid Date, Prestige Consumer Healthcare (NYSE: PBH) reported Q4 2022 earnings per share (EPS) of $1.05, up 5% year over year. Total Prestige Consumer Healthcare earnings for the quarter were $51.95 million. In the same quarter last year, Prestige Consumer Healthcare's earnings per share (EPS) was $1.00.
As of Q2 2023, Prestige Consumer Healthcare's earnings has grown 11.97% year over year. This is 50.1 percentage points lower than the US Medical Distribution industry earnings growth rate of 62.07%. Prestige Consumer Healthcare's earnings in the past year totalled $210.33 million.
What is PBH's earnings date?
Prestige Consumer Healthcare's earnings date is Invalid Date. Add PBH to your watchlist to be reminded of PBH's next earnings announcement.
What was PBH's revenue last quarter?
On Invalid Date, Prestige Consumer Healthcare (NYSE: PBH) reported Q4 2022 revenue of $275.52 million up 0.38% year over year. In the same quarter last year, Prestige Consumer Healthcare's revenue was $274.47 million.
What was PBH's revenue growth in the past year?
As of Q2 2023, Prestige Consumer Healthcare's revenue has grown 4.84% year over year. This is 2.84 percentage points lower than the US Medical Distribution industry revenue growth rate of 7.68%. Prestige Consumer Healthcare's revenue in the past year totalled $1.11 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.